Camber Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.2M | Sell |
250,000
-100,000
| -29% | -$17.3M | 4.05% | 7 |
|
|
2025
Q1 | $54.6M | Sell |
350,000
-450,000
| -56% | -$70.1M | 1.94% | 11 |
|
|
2024
Q4 | $110M | Buy |
800,000
+100,000
| +14% | +$13.8M | 2.55% | 11 |
|
|
2024
Q3 | $105M | Buy |
+700,000
| New | +$105M | 3.32% | 10 |
|
|
2024
Q1 | – | Sell |
-165,000
| Closed | -$20.8M | – | 35 |
|
|
2023
Q4 | $20.8M | Buy |
+165,000
| New | +$20.8M | 0.53% | 28 |
|
|
2020
Q3 | – | Sell |
-350,000
| Closed | -$51.8M | – | 36 |
|
|
2020
Q2 | $51.8M | Sell |
350,000
-186,710
| -35% | -$27.6M | 2.96% | 12 |
|
|
2020
Q1 | $60.4M | Sell |
536,710
-126,290
| -19% | -$14.2M | 3.61% | 13 |
|
|
2019
Q4 | $92.2M | Buy |
663,000
+13,000
| +2% | +$1.81M | 4.69% | 7 |
|
|
2019
Q3 | $62.6M | Hold |
650,000
| – | – | 3.29% | 13 |
|
|
2019
Q2 | $74.8M | Buy |
650,000
+220,000
| +51% | +$25.3M | 3.49% | 10 |
|
|
2019
Q1 | $50.6M | Buy |
+430,000
| New | +$50.6M | 2.52% | 17 |
|